Previous 10 | Next 10 |
home / stock / qgen / qgen articles
QIAGEN N.V. (NYSE: QGEN) recently lauded the new guidelines in the United States that recommend screening at-risk children of all ages for lat...
Friday, the FDA granted accelerated approval to Bristol Myers Squibb & Co’s (NYSE:BMY) Krazati (adagrasib) in combination with cetux...
U.S. stock futures were higher this morning, with the Nasdaq futures gaining around 100 points on Thursday. Shares of Vanda Pharmaceuticals Inc. (N...
Earnings reports and a dovish stance from the Federal Reserve lifted stocks last week. Major indices reacted positively, particularly to ...
U.S. stocks are looking to build on past week’s gains, with the mood remaining cautiously optimistic. The major index futures were modestly h...
Corporate earnings came to the market’s rescue in the past week, helping to overcome rate fears. As we look ahead to the unfolding week, it r...
Goldman Sachs has upgraded Twist Bioscience Corp (NASDAQ:TWST) looking forward to 2024 and beyond, and the analyst sees the critical...
QIAGEN N.V. (NYSE: QGEN) disclosed its expansion plan in the Middle East region. The company plans to open its regional headquarters in R...
Qiagen NV (NYSE: QGEN) has a steady income from selling tools for preparing samples and diagnostics. This kind of business tends to stay stron...
News, Short Squeeze, Breakout and More Instantly...
Qiagen N.V. Company Name:
QGEN Stock Symbol:
NYSE Market:
Germantown, Maryland, and Venlo, the Netherlands, June 27, 2024 (GLOBE NEWSWIRE) -- QIAGEN (NYSE: QGEN; Frankfurt Prime Standard: QIA) today announced that it welcomes new guidelines in the United States that recommend screening at-risk children of all ages for latent tuberculosis (TB) infection ...
2024-06-26 19:26:00 ET Stock Traders Daily has produced this trading report using a proprietary method. This methodology seeks to optimize the entry and exit levels to maximize results and limit risk, and it is also applied to Index options, ETFs, and futures for our subscribers. This...
2024-06-17 11:15:03 ET Citigroup analyst issues BUY recommendation for QGEN on June 17, 2024 09:43AM ET. The previous analyst recommendation was Buy. QGEN was trading at $43.115 at issue of the analyst recommendation. The overall analyst consensus : BUY. Current anal...